Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Kidney Diseases × Blood Specimen Collection × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 49 Neoplasms 40 Lung Neoplasms 26 Colorectal Neoplasms 26 Carcinoma, Non-Small-Cell Lung 22 Prostatic Neoplasms 18 Melanoma 17 Pancreatic Neoplasms 12 Ovarian Neoplasms 12 Multiple Myeloma 11 Sarcoma 10 Lymphoma 10 Leukemia, Myeloid, Acute 10 Uterine Cervical Neoplasms 9 Neoplasm Metastasis 9 Hematologic Neoplasms 9 Glioblastoma 9 Colonic Neoplasms 9 Neoplastic Cells, Circulating 8 Head and Neck Neoplasms 8 Glioma 8 Carcinoma, Hepatocellular 7 Myelodysplastic Syndromes 6 Brain Neoplasms 6 Lymphoma, Follicular 5 Leukemia 5 Hodgkin Disease 5 Uveal Melanoma 4 Urinary Bladder Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4

Interventions

Sunitinib 3 avelumab 2 Axitinib 2 trifluridine tipiracil drug combination 1 trebananib 1 spartalizumab 1 pembrolizumab 1 etelcalcetide hydrochloride 1 enzalutamide 1 cabozantinib 1 bicalutamide 1 atezolizumab 1 aldesleukin 1 Valsartan 1 VMBP protocol 1 Stents 1 Sorafenib 1 Receptors, Androgen 1 Plasma Exchange 1 Pharmaceutical Preparations 1 Paclitaxel 1 Oxaliplatin 1 Nutrition Assessment 1 Nivolumab 1 Nephrotomy 1 Nephrostomy, Percutaneous 1 Lysine Acetyltransferase 5 1 Leuprolide 1 Kidney Transplantation 1 Interleukin-2 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02822404 2022-04-25

CysPed

University Hospital, Toulouse

Phase NA Completed

Kidney Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡